SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
hhhlq
Lv3
260 积分
2023-05-25 加入
最近求助
最近应助
互助留言
OA09.04 ILLUMINATE: Efficacy and Safety of Durvalumab-Tremelimumab and Chemotherapy in EGFR Mutant NSCLC Following Progression on EGFR Inhibitors
3个月前
已完结
Is Real-World Evidence on Acquired Resistance to Osimertinib Relevant Clinically?
3个月前
已完结
GRP78 blockade overcomes acquired resistance to EGFR-tyrosine kinase inhibitors in non-small cell lung cancer
3个月前
已完结
Correspondence to: Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
3个月前
已完结
Brigatinib, a newly discovered AXL inhibitor, suppresses AXL-mediated acquired resistance to osimertinib in EGFR-mutated non-small cell lung cancer
3个月前
已完结
Antibody-drug conjugates for non-small cell lung cancer: Advantages and challenges in clinical translation
3个月前
已完结
1378P A single-center, prospective, open-label, single-arm trial of sintilimab with paclitaxel and carboplatin as a neoadjuvant therapy for esophageal squamous carcinoma
4个月前
已完结
Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
4个月前
已完结
Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)
4个月前
已完结
Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)
4个月前
已完结
没有进行任何应助
感谢
4个月前
感谢
4个月前
感谢
4个月前
感谢,点赞,速度真快,帮大忙了
4个月前
感谢,点赞,速度真快
5个月前
点赞,速度真快,帮大忙了
5个月前
感谢,点赞,速度真快,帮大忙了
8个月前
感谢,点赞,速度真快,帮大忙了
1年前
谢谢麻烦了
1年前
感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论